人妻少妇免费午夜无码区,久久爆乳AⅤ无码一区二区,日本精品久久久久影院日本,99精品66AV99精品

德思特生物專注于中藥(植物藥)物質基礎研究以及天然化合物、中藥化學對照品實物生產供應


天然藥物活性單體及中藥對照品專業生產供應商


聯系方式

028-85003950

聯系方式

服務熱線:

028-8500-3950

公司傳真:028-85589956
公司郵箱:sales@tcmlmt.com
公司網址:hamilton.org.cn
公司地址:四川省成都市溫江區海科路西段128號5棟


發表文獻展示

當前位置:首頁關于德思特 > 發表文獻展示 >

Biochemical Pharmacology-13 May 2020 黃芩素

時間:2020-09-03   瀏覽次數:  分享到:

Baicalein mediates protection against Staphylococcus aureus-induced pneumonia by inhibiting the coagulase activity of vWbp

期刊名:Biochemical Pharmacology
文獻編號:DOI 10.1016/j.bcp.2020.114024
文獻地址:https://www.sciencedirect.com/science/article/abs/pii/S0006295220302513?via%3Dihub
發表日期:13 May 2020

Abstract
The emergence and spread of multidrug-resistant Staphylococcus aureus (S. aureus) necessitate the research on therapeutic tactics which are different from classical antibiotics in overcoming resistance and treating infections. In S. aureus, von Willebrand factor-binding protein (vWbp) is one of the key virulence determinants because it mediates not only the activation of thrombin to convert fibrinogen to fibrin, thereby enabling S. aureus to escape from the host immune clearance, but also the adhesion of S. aureus to host cells. Thus, vWbp is regarded as a promising druggable target to treat S. aureus-associated infections. Here we identify that baicalein, a natural compound isolated from the Chinese herb Scutellaria baicalensis, can effectively block the coagulase activity of vWbp without inhibiting the growth of the bacteria. Through thermal shift and fluorescence quenching assays, we demonstrated that baicalein directly binds to vWbp. Molecular dynamics simulations and mutagenesis assays revealed that the Asp-75 and Lys-80 residues are necessary for baicalein binding to vWbp. Importantly, we demonstrated that baicalein treatment attenuates the virulence of S. aureus and protects mice from S. aureus-induced lethal pneumonia. In addition, baicalein can improve the therapeutic effect of penicillin G by 75% in vivo. These findings indicate that baicalein might be developed as a promising therapeutic agent against drug-resistant S. aureus infections.

 Baicalein was purchased from Chengdu Desite Biological Technology Co. Ltd (Wenjiang District, Chengdu, China)


 

熱門新聞

Afrormosine CAS:550-79-8 中藥對照品標準品

產品編碼:DA0040產品名稱:Afrormosine英文名:AfrormosineCAS登錄...

查看更多

德思特
版權所有:成都德思特生物技術有限公司 Copyright © 2016   蜀ICP備16023840號-2
公司地址:四川省成都市溫江區海科路西段128號5棟
公司電話:028-85003950

掃一掃關注德思特
   掃碼關注公眾號
主站蜘蛛池模板: 长子县| 罗城| 化德县| 怀集县| 陆良县| 中西区| 永年县| 五寨县| 西乌珠穆沁旗| 曲松县| 应城市| 济宁市| 三门峡市| 怀集县| 陵川县| 山丹县| 清涧县| 临武县| 玉环县| 温泉县| 福泉市| 宁阳县| 景东| 云安县| 安新县| 丹凤县| 平湖市| 东城区| 华蓥市| 赤城县| 青阳县| 壤塘县| 嫩江县| 陆良县| 昌黎县| 齐河县| 小金县| 大方县| 哈巴河县| 依安县| 嘉禾县|